Tuula Lehtinen

2.7k total citations
26 papers, 464 citations indexed

About

Tuula Lehtinen is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Tuula Lehtinen has authored 26 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 9 papers in Immunology. Recurrent topics in Tuula Lehtinen's work include Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (8 papers) and Herpesvirus Infections and Treatments (4 papers). Tuula Lehtinen is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (8 papers) and Herpesvirus Infections and Treatments (4 papers). Tuula Lehtinen collaborates with scholars based in Finland, Denmark and Sweden. Tuula Lehtinen's co-authors include Matti Lehtinen, Pauli Leinikki, Risto Aine, Christer Sundström, M. Alavaikko, Jorma Paavonen, Hans Hagberg, Martin‐Leo Hansmann, Pentti Koskela and Ola Lindén and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, American Journal of Epidemiology and Clinical Cancer Research.

In The Last Decade

Tuula Lehtinen

26 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tuula Lehtinen Finland 14 238 201 135 73 67 26 464
Caterina Fusco Italy 11 309 1.3× 161 0.8× 205 1.5× 152 2.1× 43 0.6× 22 616
Pierre‐Yves Le Prise France 11 185 0.8× 194 1.0× 171 1.3× 100 1.4× 26 0.4× 14 633
Kouichi Ohshima Japan 11 189 0.8× 126 0.6× 115 0.9× 68 0.9× 59 0.9× 33 403
L. Morosato Italy 13 164 0.7× 124 0.6× 291 2.2× 77 1.1× 81 1.2× 20 518
Jeffrey A. Schrager United States 7 238 1.0× 237 1.2× 216 1.6× 85 1.2× 71 1.1× 9 592
Pascal Bourquard France 10 197 0.8× 271 1.3× 91 0.7× 105 1.4× 84 1.3× 19 530
Lesley Shield United Kingdom 12 332 1.4× 377 1.9× 172 1.3× 47 0.6× 90 1.3× 17 568
Kae Shimazaki Japan 13 298 1.3× 185 0.9× 130 1.0× 58 0.8× 48 0.7× 18 510
DH Wright United Kingdom 6 273 1.1× 309 1.5× 110 0.8× 31 0.4× 49 0.7× 6 442
Karthik A. Ganapathi United States 13 223 0.9× 203 1.0× 223 1.7× 93 1.3× 57 0.9× 22 616

Countries citing papers authored by Tuula Lehtinen

Since Specialization
Citations

This map shows the geographic impact of Tuula Lehtinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuula Lehtinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuula Lehtinen more than expected).

Fields of papers citing papers by Tuula Lehtinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuula Lehtinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuula Lehtinen. The network helps show where Tuula Lehtinen may publish in the future.

Co-authorship network of co-authors of Tuula Lehtinen

This figure shows the co-authorship network connecting the top 25 collaborators of Tuula Lehtinen. A scholar is included among the top collaborators of Tuula Lehtinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuula Lehtinen. Tuula Lehtinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haapasaari, Kirsi‐Maria, Raija Sormunen, Tuula Lehtinen, et al.. (2017). Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma. Carcinogenesis. 38(8). 812–820. 23 indexed citations
2.
Kuitunen, Hanne, Taina Turpeenniemi‐Hujanen, Sirpa Leppä, et al.. (2015). Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study. Acta Oncologica. 54(6). 939–943. 15 indexed citations
3.
Hartmann, Sylvia, Mine Eray, Claudia Döring, et al.. (2014). Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology. BMC Cancer. 14(1). 332–332. 18 indexed citations
4.
Pylvänäinen, Kirsi, Tuula Lehtinen, Ilmo Kellokumpu, Heikki Järvinen, & Jukka‐Pekka Mecklin. (2012). Causes of death of mutation carriers in Finnish Lynch syndrome families. Familial Cancer. 11(3). 467–471. 18 indexed citations
5.
Wahlin, Björn E., Christer Sundström, Harald Holte, et al.. (2011). T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab. Clinical Cancer Research. 17(12). 4136–4144. 41 indexed citations
6.
Agborsangaya, Calypse, Tuula Lehtinen, Adetunji T. Toriola, et al.. (2010). Association between Epstein–Barr virus infection and risk for development of pregnancy-associated breast cancer: Joint effect with vitamin D?. European Journal of Cancer. 47(1). 116–120. 8 indexed citations
7.
Tedeschi, Rosamaria, Tapio Luostarinen, Davit Bzhalava, et al.. (2009). No Risk of Maternal EBV Infection for Childhood Leukemia. Cancer Epidemiology Biomarkers & Prevention. 18(10). 2790–2792. 12 indexed citations
8.
Melbye, Mads, Karin E. Smedby, Tuula Lehtinen, et al.. (2007). Atopy and Risk of Non-Hodgkin Lymphoma. JNCI Journal of the National Cancer Institute. 99(2). 158–166. 51 indexed citations
9.
Jantunen, Esa, Maija Itälä, Tuula Lehtinen, et al.. (2002). Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma. Leukemia & lymphoma. 43(6). 1229–1237. 13 indexed citations
10.
Lehtinen, Tuula & Matti Lehtinen. (1998). Common and emerging infectious causes of hematological malignancies in the young. Apmis. 106(1-6). 585–597. 3 indexed citations
11.
Alavaikko, M., Guillermo Blanco, Risto Aine, et al.. (1994). Follicular Dendritic Cells Have Prognostic Relevance in Hodgkin’s Disease. American Journal of Clinical Pathology. 101(6). 761–767. 32 indexed citations
12.
Lehtinen, Tuula, et al.. (1993). Evaluation of Plasma Levels of Thymidine Kinase and Mutated P53 in 81 Patients with Newly Diagnosed Malignant Lymphoma. Acta Oncologica. 32(7-8). 779–781. 7 indexed citations
13.
Lehtinen, Matti, Arto Leminen, Tapio Kuoppala, et al.. (1992). Pre‐ and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma. Journal of Medical Virology. 37(3). 180–186. 24 indexed citations
14.
Lehtinen, Tuula, Jorma Isola, Risto Aine, M. Alavaikko, & Matti Lehtinen. (1992). Accumulation of p53 protein correlates with tumour proliferative activity in EBV positive Burkitt's lymphoma. Hematological Oncology. 10(5). 273–279. 8 indexed citations
15.
Aine, Risto, Tuula Lehtinen, Matti Lehtinen, et al.. (1990). Flow cytometric analysis of DNA ploidy in large cleaved cell lymphomas. Hematological Oncology. 8(6). 339–346. 2 indexed citations
16.
Lehtinen, Tuula, Risto Aine, Matti Lehtinen, et al.. (1989). Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non‐Hodgkin lymphomas. The Journal of Pathology. 157(1). 27–36. 41 indexed citations
17.
Lehtinen, Matti, et al.. (1988). Phospholipase A<sub>2</sub> Activity Is Copurified Together with Herpes simplex Virus-Specified Fc Receptor Proteins. Intervirology. 29(1). 50–56. 4 indexed citations
18.
Lehtinen, Matti, Klaus Teisala, Pentti K. Heinonen, et al.. (1986). Detection of Herpes Simplex Virus in Women with Acute Pelvic Inflammatory Disease. Obstetrical & Gynecological Survey. 41(4). 250–251. 1 indexed citations
19.
20.
Lehtinen, Matti, et al.. (1985). Serum antibodies to the major HSV‐2‐ specified DNA‐binding protein in patients with an acute HSV infection or cervical neoplasia. Journal of Medical Virology. 16(3). 245–256. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caterina Fusco Breakdown of academic impact, for papers by Pierre‐Yves Le Prise Breakdown of academic impact, for papers by Kouichi Ohshima Breakdown of academic impact, for papers by L. Morosato Breakdown of academic impact, for papers by Jeffrey A. Schrager Breakdown of academic impact, for papers by Pascal Bourquard Breakdown of academic impact, for papers by Lesley Shield Breakdown of academic impact, for papers by Kae Shimazaki Breakdown of academic impact, for papers by DH Wright Breakdown of academic impact, for papers by Karthik A. Ganapathi
Rankless by CCL
2026